Characterization of [3H]substance P binding sites in human skin

J Eur Acad Dermatol Venereol. 1999 Jan;12(1):6-10.

Abstract

Radioligand binding experiments were performed with crude homogenates from normal human skin in order to investigate substance P receptor density. Binding of [3H]substance P ([3H]SP) reached equilibrium after 20 min and was saturable analysis of saturation curves gave a significantly better fit using two-site binding compared to the single-site model. Competition studies employing some selective agonists for NK1, NK2 and NK3 receptors have demonstrated that only the NK1 selective agonist, [Sar9, Met(O2)11]-SP, was a competitor for [3H]SP binding. In addition, the non-hydrolyzable guanosine 5'-0-(3-thiotriphosphate) altered the dissociation of SP from NK1 receptors by increasing the number of low-affinity sites. These data show that in the skin [3H]SP binds to a single population of substance P high-affinity sites, which represent NK1-type receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Binding, Competitive / drug effects
  • Female
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Humans
  • Male
  • Middle Aged
  • Neurokinin A / analogs & derivatives
  • Neurokinin A / pharmacology
  • Neurokinin B / analogs & derivatives
  • Neurokinin B / pharmacology
  • Peptide Fragments / pharmacology
  • Radioligand Assay
  • Receptors, Neurokinin-1 / agonists
  • Receptors, Neurokinin-1 / metabolism
  • Receptors, Neurokinin-2 / agonists
  • Receptors, Neurokinin-3 / agonists
  • Skin / drug effects
  • Skin / metabolism*
  • Substance P / analogs & derivatives
  • Substance P / metabolism*
  • Substance P / pharmacology
  • Tritium

Substances

  • Peptide Fragments
  • Receptors, Neurokinin-1
  • Receptors, Neurokinin-2
  • Receptors, Neurokinin-3
  • neurokinin B, MePhe(7)-
  • Tritium
  • substance P, Sar(9)-Met(O2)(11)-
  • neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-
  • Substance P
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Neurokinin A
  • Neurokinin B